New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya
- 1 March 2009
- journal article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 87 (3) , 186-192
- https://doi.org/10.2471/BLT.08.051474
Abstract
To develop new methods for estimating the sputum smear-positive tuberculosis case detection rate (CDR) in a country where infection with HIV is prevalent. We estimated the smear-positive tuberculosis CDR in HIV-negative and HIV-positive adults, and in all adults in Kenya. Data on time trends in tuberculosis case notification rates and on HIV infection prevalence in adults and in tuberculosis patients were used, along with data on tuberculosis control programme performance. In 2006, the estimated smear-positive tuberculosis CDR in HIV-negative adults was 79% (95% confidence interval, CI: 64–94) and in HIV-positive adults, 57% (95% CI: 26–88), giving a weighted mean of 68% (95% CI: 49–87). The separate estimate for all smear-positive tuberculosis cases was 72% (95% CI: 53–91), giving an overall average for the three estimates of 70% (95% CI: 58–82). As the tuberculosis CDR in 1996 was 57% (95% CI: 47–67), the estimated increase by 2006 was 13 percentage points (95% CI: 6–20), or 23%. This increase was accompanied by a more than doubling of the resources devoted to tuberculosis control in Kenya, including facilities and staff. Using three approaches to estimate the tuberculosis CDR in a country where HIV infection is prevalent, we showed that expansion of the tuberculosis control programme in Kenya led to an increase of 23% in the CDR between 1996 and 2006. While the methods developed here can be applied in other countries with a high prevalence of HIV infection, they rely on precise data on trends in such prevalence in the general population and among tuberculosis patients.This publication has 25 references indexed in Scilit:
- Survival Rate and Risk Factors of Mortality Among HIV/Tuberculosis-Coinfected Patients With and Without Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaClinical Infectious Diseases, 2005
- Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income CountriesClinical Infectious Diseases, 2005
- Tuberculosis control in the era of HIVNature Reviews Immunology, 2005
- How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold MinersThe Journal of Infectious Diseases, 2005
- Stable Incidence Rates of Tuberculosis (TB) among Human Immunodeficiency Virus (HIV)–Negative South African Gold Miners during a Decade of Epidemic HIV‐Associated TBThe Journal of Infectious Diseases, 2003
- Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDSScience, 2003
- Estimating HIV incidence rates from age prevalence data in epidemic situationsStatistics in Medicine, 2001
- A prospective study of the risk of tuberculosis among HIV-infected patientsAIDS, 1993
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989